Prescribing across state lines: licensure, DEA, and the pharmacy that refuses

Which state's law controls when the patient is elsewhere

The state where your patient is physically sitting at the moment of the visit controls the encounter — you need an active license there, not merely where your office is. Telehealth does not move the patient to you; the law treats the visit as happening at the patient's location. A prescription written into that visit inherits the same rule, so an out-of-state license gap voids both the visit and the script.

Because each state board defines the practice of medicine and nursing inside its own borders, there is no national prescribing license — the variation is the rule, not the exception, which is what makes cross-border prescriptions their own problem. Video-based psychiatric care is governed by that patient's-location licensure principle, and its practice, legal, and reimbursement dimensions are worth reviewing before you open a state 1Ref 1American Psychiatric Association (2026).Telepsychiatry Toolkit.That video-based psychiatric care is governed by the patient's-location licensure principle, with practice, legal, and reimbursement dimensions to review before opening a new state.. If a patient travels across the border to another country, U.S. licensure and DEA authority generally do not follow them, and prescribing into a foreign jurisdiction is a separate question you should not answer from your U.S. credentials alone.

The multistate compacts — your licensure path

There is no single national license to prescribe; each state licenses practitioners inside its own borders, which is why interstate compacts exist to shorten the path. The Interstate Medical Licensure Compact gives qualifying physicians an expedited route to a full, separate license in each member state — one license per state, not one license honored everywhere. Nurses, including PMHNPs at the RN layer, use the Nurse Licensure Compact for a single multistate RN license.

When you are adding a state to your practice, the compact route is usually faster than a fresh license-by-endorsement application, though you still hold — and renew — a license in each state the compact reaches. A few caveats:

• The IMLC issues a full, separate license in each member state; it is not one license honored everywhere 2Ref 2Interstate Medical Licensure Compact Commission (2026).Interstate Medical Licensure Compact.That the IMLC provides physicians an expedited path to a full, separate license in each member state — a license per state, not one multistate license.. Cite the compact's site at imlcc.com for the current member list.
• The Nurse Licensure Compact covers the RN layer; APRN authority — including PMHNP prescribing — runs through a separate, narrower APRN compact that fewer states have adopted 3Ref 3National Council of State Boards of Nursing (2026).NURSECOMPACT — Nurse Licensure Compact.That the NLC gives RNs/LPNs one multistate license honored in member states, relevant to a PMHNP's RN layer, while APRN multistate authority runs through a separate, narrower compact..
• Counselors, clinical social workers, and psychologists have their own compacts — the Counseling Compact among them — so if your practice includes therapists, their cross-state path is a different mechanism from yours 4Ref 4Counseling Compact Commission (2026).Counseling Compact.That non-prescribing clinicians such as licensed counselors have their own cross-state compacts, distinct from the prescriber licensure path..

Confirm your target state has not only enacted but implemented the compact you plan to use; enacted-but-not-yet-live is common, and only implementation grants the privilege.

DEA registration is tied to a location, not to you

Your DEA registration attaches to a physical location, not to you as a roaming individual: DEA has long required a separate registration for each state where you maintain a location that dispenses, administers, or stores controlled substances. Whether a purely remote prescriber needs a registration in the patient's state is a live regulatory question, so confirm the current requirement with DEA's Diversion Control Division before you write a controlled substance across a state line 5Ref 5Drug Enforcement Administration (2026).Diversion Control Division.That DEA's Diversion Control Division administers practitioner registration, telemedicine controlled-substance prescribing rules, and the pharmacist's corresponding-responsibility obligation..

Practically, that means three things for a solo prescriber working across lines:

• Keep every DEA registration current and matched to a real address where you actually handle controlled substances; the registration is location-specific, not a personal passport.
• Before you add a state where you will store or administer controlled substances, budget for a registration there plus the separate state controlled-substance registration many states layer on top.
• For purely remote prescribing, do not assume your home registration reaches the patient's state — verify against the Diversion Control Division's current guidance rather than a forum answer.

Controlled substances by telehealth: the extra layer

Controlled substances by telehealth carry a second layer beyond licensure. The Ryan Haight Act generally requires an in-person evaluation before a controlled-substance prescription, subject to telemedicine exceptions. As of July 2026, the pandemic-era flexibility that allowed prescribing without an in-person exam has been extended by DEA rulemaking rather than made permanent, and its terms and expiration keep moving. Treat any date you remember as stale and check the Diversion Control Division for the flexibility's current status before relying on it 5Ref 5Drug Enforcement Administration (2026).Diversion Control Division.That DEA's Diversion Control Division administers practitioner registration, telemedicine controlled-substance prescribing rules, and the pharmacist's corresponding-responsibility obligation..

Schedule II stimulants add their own schedule ii logistics: no refills are permitted, so each month is a separate prescription that must be transmitted anew, by EPCS or a compliant script. When the patient sits in another state, plan the cadence so a cross-state fill is not left waiting on a script the pharmacy then questions. Never extrapolate a proposed rule into a current one — a comment period is not authority, and the in-person-exam exception, not the prescription itself, is where cross-state prescribing most often breaks.

Check the patient's state PDMP, not only your own

Query the prescription drug monitoring program in the state where the patient is located, not only your own. Most states mandate a PDMP check before prescribing controlled substances, and the mandate, the schedules it covers, and the lookback window are set state by state. When you prescribe across a state line, you are operating under the patient's state rule, and its portal may require separate registration you have to arrange in advance 6Ref 6PDMP Training and Technical Assistance Center (2026).Prescription Drug Monitoring Program Training and Technical Assistance Center.That every state operates a PDMP and most mandate a query before controlled-substance prescribing, with the mandate and access rules set state by state..

The federally funded PDMP clearinghouse keeps state-by-state profiles, which is the fastest way to find whether the patient's state mandates a query, for which schedules, and how to get portal access before your first cross-state visit rather than after a denial. Build the check into your intake so it is done before the appointment, not scrambled for while the patient waits.

Buprenorphine and OUD across state lines

Buprenorphine for opioid use disorder no longer needs the old X-waiver — the DATA-2000 waiver was eliminated in 2023, so any prescriber whose DEA registration includes Schedule III authority may prescribe it after a one-time training attestation 7Ref 7Substance Abuse and Mental Health Services Administration (2026).Buprenorphine.That the X-waiver was eliminated in 2023, so any prescriber with Schedule III authority and a current DEA registration may prescribe buprenorphine for OUD after a one-time training attestation.. Across a state line the same two-layer test governs: licensure in the patient's state, plus the controlled-substance telemedicine rules, because buprenorphine is a scheduled drug and the flexibility framing above reaches it too. The pharmacy still exercises its own judgment on the fill.

Office-based OUD treatment is one of the places a solo prescriber can genuinely extend access, but the interstate mechanics do not relax for it. Confirm the patient's-state license, the PDMP mandate, and the current telemedicine-prescribing status for the induction visit specifically — a remote start carries the same in-person-exam question as any other controlled substance, and that is the part most likely to change under new rulemaking.

The pharmacy that refuses

A pharmacy can refuse to fill a valid prescription, and out-of-state controlled-substance scripts draw the most scrutiny. The dispensing pharmacist shares legal duty for the legitimacy of a controlled-substance prescription and may decline one that raises questions — an unfamiliar out-of-state prescriber, a long distance, or a drug the pharmacy sees diverted. This is not a slight on your license; it is the pharmacist's own obligation, and no amount of your paperwork overrides their refusal.

That shared duty has a name — corresponding responsibility — and it is the pharmacist's independent obligation under DEA rules to confirm a controlled-substance prescription was issued for a legitimate medical purpose 5Ref 5Drug Enforcement Administration (2026).Diversion Control Division.That DEA's Diversion Control Division administers practitioner registration, telemedicine controlled-substance prescribing rules, and the pharmacist's corresponding-responsibility obligation.. You cannot argue a pharmacist out of it. What reduces the friction is boring and reliable: send the script to a pharmacy in the patient's own area, make yourself reachable for verification, keep your documentation tight, and warn the patient that a first out-of-state fill can take an extra call. If a pharmacy still declines, that is their right — route the patient to another pharmacy rather than pressuring the first.